Retrophin Announces Voting Results Of Special Meeting Of Stockholders

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 17th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2015 at 11:00 a.m. ET at the Waldorf Astoria in New York City. In addition, Alnylam management will present a company overview at the 2015 Leerink Global Healthcare Conference on Wednesday, February 11, 2015 at 1:25 p.m. ET at the Waldorf Astoria in New York City.

Help employers find you! Check out all the jobs and post your resume.